Los ADPIC y el TLCAN en la industria farmacéutica mexicana: Un análisis TradeCAN

the work shows the deterioration of the mexican pharmaceutical industry ever since de early nineties at the commercial, competitive and inventive activity levels, considering both inputs and final products. such a deterioration is linked to the external opening of the mexican economy, which began in 1985 with the unilateral dismantling of tariff barriers and the annexing of mexico to gatt, a year later, and advanced in 1991 with the acceptance of sector-specific trade agreements known as trip 's and the implementation of the law on the promotion and protection of industrial property, and finally the instrumentation of nafta, in 1994. to prove its hypothesis, the essay takes as a main tool the latest version of the software developed by eclac for analyzing the competitiveness of nations, known as tradecan, at five-digit sitc. it also suggests the growth of intra-firm trade of multinational pharmaceutical companies operating in mexico; quantifies intra-industry trade of mexico, which has slowed down, and presents a synthesis of views from different industry experts.